HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $89.64 billion. The enterprise value is $140.06 billion.
| Market Cap | 89.64B |
| Enterprise Value | 140.06B |
Important Dates
The last earnings date was Friday, July 24, 2026, before market open.
| Earnings Date | Jul 24, 2026 |
| Ex-Dividend Date | Sep 16, 2026 |
Share Statistics
HCA Healthcare has 216.50 million shares outstanding. The number of shares has decreased by -8.97% in one year.
| Current Share Class | 216.50M |
| Shares Outstanding | 216.50M |
| Shares Change (YoY) | -8.97% |
| Shares Change (QoQ) | -1.69% |
| Owned by Insiders (%) | 1.52% |
| Owned by Institutions (%) | 61.05% |
| Float | 138.06M |
Valuation Ratios
The trailing PE ratio is 13.86 and the forward PE ratio is 13.49. HCA Healthcare's PEG ratio is 1.38.
| PE Ratio | 13.86 |
| Forward PE | 13.49 |
| PS Ratio | 1.15 |
| Forward PS | 1.12 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 14.95 |
| P/OCF Ratio | 8.06 |
| PEG Ratio | 1.38 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.89, with an EV/FCF ratio of 23.36.
| EV / Earnings | 20.48 |
| EV / Sales | 1.80 |
| EV / EBITDA | 8.89 |
| EV / EBIT | 11.60 |
| EV / FCF | 23.36 |
Financial Position
The company has a current ratio of 0.99
| Current Ratio | 0.99 |
| Quick Ratio | 0.77 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.27 |
| Debt / FCF | 8.60 |
| Interest Coverage | 5.21 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.29% |
| Return on Invested Capital (ROIC) | 21.80% |
| Return on Capital Employed (ROCE) | 26.28% |
| Weighted Average Cost of Capital (WACC) | 7.88% |
| Revenue Per Employee | $243,791 |
| Profits Per Employee | $21,375 |
| Employee Count | 320,000 |
| Asset Turnover | 1.27 |
| Inventory Turnover | 25.94 |
Taxes
In the past 12 months, HCA Healthcare has paid $2.02 billion in taxes.
| Income Tax | 2.02B |
| Effective Tax Rate | 20.44% |
Stock Price Statistics
The stock price has increased by +8.50% in the last 52 weeks. The beta is 1.11, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +8.50% |
| 50-Day Moving Average | 389.08 |
| 200-Day Moving Average | 456.81 |
| Relative Strength Index (RSI) | 58.58 |
| Average Volume (20 Days) | 1,670,065 |
Short Selling Information
The latest short interest is 5.83 million, so 2.69% of the outstanding shares have been sold short.
| Short Interest | 5.83M |
| Short Previous Month | 5.21M |
| Short % of Shares Out | 2.69% |
| Short % of Float | 4.22% |
| Short Ratio (days to cover) | 3.40 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $78.01 billion and earned $6.84 billion in profits. Earnings per share was $29.87.
| Revenue | 78.01B |
| Gross Profit | 33.22B |
| Operating Income | 12.07B |
| Pretax Income | 9.87B |
| Net Income | 6.84B |
| EBITDA | 15.75B |
| EBIT | 12.07B |
| Earnings Per Share (EPS) | $29.87 |
Balance Sheet
The company has $1.13 billion in cash and $51.55 billion in debt, with a net cash position of -$50.42 billion or -$232.89 per share.
| Cash & Cash Equivalents | 1.13B |
| Total Debt | 51.55B |
| Net Cash | -50.42B |
| Net Cash Per Share | -$232.89 |
| Equity (Book Value) | -3.21B |
| Book Value Per Share | -30.47 |
| Working Capital | -122.00M |
Cash Flow
In the last 12 months, operating cash flow was $11.12 billion and capital expenditures -$5.13 billion, giving a free cash flow of $6.00 billion.
| Operating Cash Flow | 11.12B |
| Capital Expenditures | -5.13B |
| Depreciation & Amortization | 3.67B |
| Net Borrowing | 5.01B |
| Free Cash Flow | 6.00B |
| FCF Per Share | $27.70 |
Margins
Gross margin is 42.58%, with operating and profit margins of 15.48% and 8.77%.
| Gross Margin | 42.58% |
| Operating Margin | 15.48% |
| Pretax Margin | 12.65% |
| Profit Margin | 8.77% |
| EBITDA Margin | 20.19% |
| EBIT Margin | 15.48% |
| FCF Margin | 7.69% |
Dividends & Yields
This stock pays an annual dividend of $3.12, which amounts to a dividend yield of 0.75%.
| Dividend Per Share | $3.12 |
| Dividend Yield | 0.75% |
| Dividend Growth (YoY) | 8.51% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 10.44% |
| Buyback Yield | 8.97% |
| Shareholder Yield | 9.73% |
| Earnings Yield | 7.63% |
| FCF Yield | 6.69% |
Analyst Forecast
The average price target for HCA Healthcare is $454.57, which is 9.79% higher than the current price. The consensus rating is "Buy".
| Price Target | $454.57 |
| Price Target Difference | 9.79% |
| Analyst Consensus | Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (3Y) | 4.24% |
| EPS Growth Forecast (3Y) | 7.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.64 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.64 |
| Piotroski F-Score | 7 |